Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus Erythematosus patients: a focus on B cells.
Mitra AbbasifardZahra KamiabMohammad HasaniAmir RahnamaPooya Saeed-AskariHossein KhorramdelazadPublished in: BMC immunology (2020)
It was concluded that the release of anti-inflammatory cytokines, particularly IL-10 and TGF-β, might inhibit immune responses and autoreactive immune cells in a compensatory manner in SLE patients with mild to moderate disease activity.
Keyphrases
- systemic lupus erythematosus
- disease activity
- newly diagnosed
- rheumatoid arthritis
- rheumatoid arthritis patients
- ankylosing spondylitis
- end stage renal disease
- immune response
- juvenile idiopathic arthritis
- chronic kidney disease
- ejection fraction
- poor prognosis
- peritoneal dialysis
- prognostic factors
- transforming growth factor
- dendritic cells
- patient reported outcomes
- patient reported